Analyst Ratings For NASDAQ:AXON – Axovant Sciences (NASDAQ:AXON)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:AXON – Axovant Sciences (NASDAQ:AXON).
Some recent analyst ratings include
- 6/7/2018-HC Wainwright Reiterated Rating of Buy.
- 6/6/2018-Oppenheimer Reiterated Rating of Hold.
- 6/6/2018-Chardan Capital Reiterated Rating of Hold.
- 2/13/2018-Cowen Reiterated Rating of Hold.
- 12/21/2017-Jefferies Group was Downgraded by analysts at Jefferies Group from a “Buy ➝ Hold” rating to a “” rating. They now have a $6.00 price target on the stock.
- 11/10/2017-Piper Jaffray Companies Reiterated Rating of Hold.
- 11/1/2017-Robert W. Baird Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:AXON – Axovant Sciences (NASDAQ:AXON)
NASDAQ:AXON – Axovant Sciences (NASDAQ:AXON) has insider ownership of 72.40% and institutional ownership of 14.83%.
- On 2/27/2018 George Bickerstaff, Director, bought 25,000 with an average share price of $1.50 per share and the total transaction amounting to $37,500.00.
- On 4/17/2017 David Hung, Insider, bought 539,375 with an average share price of $18.54 per share and the total transaction amounting to $10,000,012.50.
- On 4/17/2017 W Anthony Vernon, Director, bought 53,937 with an average share price of $18.54 per share and the total transaction amounting to $999,991.98.
- On 3/10/2016 Mark Altmeyer, Insider, bought 2,300 with an average share price of $11.14 per share and the total transaction amounting to $25,622.00.
Recent Trading Activity for NASDAQ:AXON – Axovant Sciences (NASDAQ:AXON)
Shares of NASDAQ:AXON – Axovant Sciences closed the previous trading session at 5.83 up +1.28 28.13% with shares trading hands.